wsb_investor

wsb_investor | Joined since 2021-06-04

Investing Experience -
Risk Profile -

Followers

1

Following

0

Blog Posts

0

Threads

303

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
303
Past 30 days
4
Past 7 days
0
Today
0

User Comments
Stock

1 week ago | Report Abuse

I compared AIA MY and Allianz MY NB growth, Allianz is marginally higher than AIA for 2023 vs 2022, and 2023 vs 2019. Anyways AIA HK covers too many markets, and hard to put value on them, vs Allianz MY is a lot more simple.

Stock

1 week ago | Report Abuse

Allianz is currently priced at around 1x BV for GI, and 1x CSM + NAV for Life.
PBB is offering to takeover LPI @ ~1.74x BV.
In Singapore, Allianz offers to takeover NTUC @ 100% EV (failed), GE offers to privatise @ ~70% EV (not going well).
Regionally, Prudential and AIA are still trading at near record low, and FWD IPO still keep delaying due to weak market sentiment.
If GI is fully priced (based on Lonpac 1.74x), share price should be ~28.
If both Life and GI is fully priced (based on pre-covid era, life insurance valuation), share price should be ~40.

Allianz FY2023 total expense is ~650mil, while PBT is 957mil. I understand that Allianz is currently undergoing some cost saving measure, say if materialise, a 10% cut in expense, can increase PBT by 6.8%.

Immediate catalyst will depend on Anwar's healthcare reform.
Currently, Malaysia healthcare expenditure is ~50bil, of which 17% by private insurance (~8.5bil).
Allianz has ~1.5-2bil/yearly (and rising, with loss ratio ~80-90%) in medical premium/COI alone (>17% market share).
Anwar is pushing for rakan-KKM/FPP in government hospital, and supposedly in his ideal world, only B40 can enjoy RM1 healthcare, in the crowded government hospital. M40 can go for full pay gov hospital, and T20 can go private hospital. A lot room for medical insurance, if Anwar's plan success, of course, at the expenses of rakyat, and make greedy private investors richer.

Stock

2 weeks ago | Report Abuse

Expert Foresees ‘Full Privatisation’ Of MOH’s FPP Service

Stock

3 weeks ago | Report Abuse

Allianz's proposed acquisition of a 51% stake in Singapore's Income Insurance for US$1.6bn has been called off after the Singapore government intervened, stating the merger "would not be in the public interest."

Stock

1 month ago | Report Abuse

Comments on AMIB report:
i. mandatory coinsurance, on long term, is good for everyone (except private hospitals)
ii. market risk charge under RBC2 will be higher, yes, but overall risk charges might not be higher. Also, comparing CAR change from RBC to RBC2 is completely meaningless. There are new risk charges (or new components), but there are also diversification.

Stock

2024-07-31 17:21 | Report Abuse

Prudential is not the only company that foreign owns 100% via bumi proxy. GE has gotten exemption. AIA has approval from white house, probably no one dare to touch. HLA and Etiqa are local. Allianz/Manulife are listed. Sunlife/MCIS/Generali/FWD/AmMetlife all have local partner. Zurich and Tokio Marine probably still 100% foreigner own, with proxy.

Stock

2024-07-31 17:11 | Report Abuse

No,Pru plc owns 51% of PAMB. If bumi proxy can just anyhow songlap foreigner share, I think discourage Prudential from growing MY market is the least concern.

Before 1998, Pru plc owned 30% of PAMB, Berjaya owned ~69%. In 1998, Berjaya divested in PAMB, and supposedly sold all ownership back to Pru plc. However due to insurance act 1996, Pru plc cannot, on paper, own 100%, hence the Detik Ria (30% @ 1998) as bumi proxy. Vincent Tan personally also hold 19% of PAMB share at this point, only later (unknown when), sold the 19% to Detik Ria. Pru plc has signed some put and call options on the ownership of Detik Ria (i.e. fixed price) that it will repurchase back the ownership at later time.

Later in ~2017, BNM (or government) started to want to enforce the foreign ownership (now 70%), Pru plc then planned to get back the 49% and then disinvest accordingly. This Tommy, used the excuse that not getting MoF approval, but ignoring that BNM has given the approval. Next time how? listen to who? MoF or BNM?

Who is enforcing the 70%? BNM. From the article, BNM also ok with Pru plc approach, to get back 100% of share, and proceed with disinvestment accordingly. Then suddenly, VT and Tommy, come out with this idea, to songlap Pru plc ownership.



Stock

2024-07-31 00:37 | Report Abuse

Bcorp now owns 5% of Prudential Malaysia!!! Huat ar

Stock

2024-07-18 12:38 | Report Abuse

If my understanding is correct, Allianz will loan out its internal staff (under a single entity), as shared service to other BUs, and get to profit from it. A more common way is, shared service will operate as a separated entity (might or might not under local BU, typically not under local BU, but directly under Group).

Stock

2024-07-18 08:23 | Report Abuse

Allianz already has some existing shared service in Malaysia, but in a very weird arrangement.

Stock

2024-07-17 17:27 | Report Abuse

Allianz has announced a pre-conditional voluntary cash general offer to acquire at least 51% of the shares of Income Insurance, subject to regulatory approval. Allianz intends to offer $40.58 per share for a total transaction value of approximately $2.2 billion (approximately EUR 1.5 billion) for 51% of the shares in Income Insurance. The offer price represents a premium over Income's NAV of $29.55 per share of 37.3%.

Stock

2024-07-09 09:59 | Report Abuse

For many white collar office job, you (and maybe your family) already covered by your employer's group insurance. There is no real need for you to have a cashless medical insurance.

Stock

2024-07-09 09:56 | Report Abuse

Many hoo-ha with co-payment medical insurance recently. Insurers are already moving away from cashless, yet some doctor association/consumer group jump out and said, cashless is better. Many people don't see the point that, the saving in premium, will higher than the deductible in just 2-3 years time. You might need to fork out RM500 or RM1000 for admission, but you save back premium (and hidden commission) in 2-3 years. There is no free lunch, for everyone, but dropping the cashless feature, will introduce a great saving immediately.

Stock

2024-06-29 18:16 | Report Abuse

New RBC framework just out yesterday, effectively 2027, but will have immediate impact on product mix starting next year.

Stock

2024-06-14 23:25 | Report Abuse

Income Insurance, Allianz in talks on tie-up, seeking regulatory approval

Stock

2024-05-29 11:33 | Report Abuse

just a hypothetical number, could be 3x 5x, could also just be 2x.

Stock

2024-05-27 01:33 | Report Abuse

In fact, in a way yes, for single premium product, there is 0 capital upfront. For ILP (regardless if conventional or takaful), there will be a strain, and a limit of how much can sell at a point.

So, in theory, say if we got 1.4bil population, STMB can immediately sell 45x of MRTA, but Allianz probably can only sell 3x of ILP before being restricted by the capital.

However, this is not meaningful at all. And similarly focus on ROE is not meaningful as well. MRTA is good, profitable business, but in the end, still restricted by how many new house loan by your bank partner.

Stock

2024-05-19 01:08 | Report Abuse

No right or wrong. But need to know product strategy and maximise bancassurance channel. Etiqa as example, become top 6 purely with bancassurance, but another Tokio Marine, struggle to have meaningful market share with RHB bancassurance. HLA got mix of agency and banca, not sure with the split.

Stock

2024-05-18 23:09 | Report Abuse

Yes, but less volatile vs pre IFRS17.

Short term, negative impact to capital, might reduce ability to pay dividend etc. Long term, higher yield will have positive impact to future profit.

Stock

2024-05-18 20:13 | Report Abuse

Diluted NTA is just RM14.85.
While it is possible to reach RM30, probably won't happen in 3 years time. RM25 probably max for this year.

Stock

2024-05-14 16:30 | Report Abuse

If not mistaken, great eastern adopts a very aggressive method to calculate future profit from medical business, something like always reprice 10% annually hence the Pv profit can become very unrealistic (in my view). However, not sure how the normal retail shareholders view it, since they won't have such info.

Stock

2024-05-14 16:28 | Report Abuse

筹资跨足电影业
大马保险代理Norman Pang
明年新加坡上市

Stock

2024-05-10 14:57 | Report Abuse

OCBC takes Great Eastern private @ S$25.60 per share, last traded price of S$18.70, embedded value per share = S$36.59.

Stock

2024-04-24 11:48 | Report Abuse

Exact % varies by product, but in most case, you will not able to get back any commission paid, and some expenses incurred (typically relatively negligible, except for small ticket size policy).

Stock

2024-04-24 09:15 | Report Abuse

It could be true that maybe 20% people lapse the contract in first year (in this year), and probably get back less than half of initial premium paid. I don't think it will over 50%, even the most lousy tier 3 insurers also have better persistency. And no, insurers do not profit from this. BNM actually prohibits insurers to profit in this manner. Agents that "profit" from it, even if a whole life ILP only lasts for one year, the first year ~40% commission still need to pay to agents.

Stock

2024-04-23 09:04 | Report Abuse

technically, yes, you can do that too, but most of the time, after repricing, your total premium will increase, say to 1200 (400 to life, 800 to medical), then to 1600 (400 to life, 1200 to medical) and so on.

Stock

2024-04-21 20:20 | Report Abuse

Medical insurance by itself (either standalone or rider) is not that profitable (in %) vs other line, e.g. personal accident, life, waiver, CI etc. However, it contributes to the largest absolute amount. e.g. if you have a breakdown of the premium for each components of your investment-linked plan, medical will be > 50% of the total premium.

Unique for medical insurance is the ability to reprice, and higher future profit. Your ILP now could be 40% premium to life (fixed, say 400) and 60% premium to medical. After 10 years, say 3 rounds of repricing, the breakdown could be 400 to life, 1000 to medical. The ability to reprice, essentially also meant, insurers are guaranteed never lost any money in this block of business over the long term.

Stock

2024-04-12 21:15 | Report Abuse

Essentially, for protection business, insurers will earn a x% of total claims payment. And for Malaysia, medical claims are a lot higher than life claims.

Stock

2024-04-10 21:20 | Report Abuse

No, there are other loading for commission and expense. Usually commission is fine, since you will incur as you sold, not much variance there, except for outperformance related. Expenses then a different story. Your expense loading might (and usually) insufficient to meet actual expenses. And the 25% margin for medical, is just expected. Medical service will rise by inflation, rapidly. It might be 25% now, then erode to 15% by year end.

Stock

2024-04-10 12:53 | Report Abuse

The 25% is only cost of insurance, over paid claims. Not including any expenses. Any previous IFRS4 / IFRS17 profit margin is not meaningful.

Stock

2024-03-04 09:09 | Report Abuse

No, should be just 4th (by NB volume), 5th by IF volume (HLA 4th). Key difference between HLA and Allianz Life is the proportion of investment linked business (most profitable) over total business.

Stock

2024-03-01 09:57 | Report Abuse

There is a new guideline on medical insurance by BNM yesterday. BNM push for coinsurance (lower premium, higher margin), and mandate that future reprice premium cannot higher than initial profit margin. BNM also push for a centralized data platform for medical claims.

Stock

2024-01-28 18:42 | Report Abuse

Malaysia don't have rubbish financial products like the US, but we have rubbish politicians. The only remotely possible way Allianz will bankrupt in near future is government/BNM doesn't allow medical repricing. It took the industry quite a while to make general public and BNM understand that repricing is inevitable, but then I don't think Malaysia politicians will really honor what the previous government has agreed upon and can just u-turn anytime, doing anything for the sake of vote. Looking back past 10 years, insurance companies have been force to donate to mysalam, 70% ownership, delay repricing during covid, donation during covid etc, on top of a general prosperity tax in 2022.

Stock

2024-01-16 20:58 | Report Abuse

you cant fake death or fake critical illness, but very easy to fake hospital admission.

Stock

2024-01-16 09:59 | Report Abuse

660k is your annual limit. 99% of the claims, the amount will not exceed 100k, but the average claims amount will keep increasing. 660k annual limit, or unlimited limit medical card, the actual coverage policyholders entitle for in next 10 years, will have minimal difference.

Stock

2024-01-15 23:37 | Report Abuse

Nowhere on earth that medical insurance rate is fixed, simply because you will not able to price in all future inflation, hence naturally it will only be short term basis, and will require frequent repricing. Medical insurance margin, in % is actually one of the lowest, and it is a lot harder to manage it vs say death claims.

Stock

2024-01-15 16:16 | Report Abuse

The first real round of medical repricing started in ~2015/2016. Prior to that, yes, many life insurance operate at a loss on their medical business. Because of that, previously there is no fancy million dollar limit / unlimited coverage, sort of like limit the coverage in order to minimize losses.
After 2015/2016, BNM is more "open" to actuarially sounded medical repricing, and then we started to see fancy medical coverage.

Stock

2024-01-15 16:13 | Report Abuse

A sense of how medical COI rates exponentially increasing as we age, age 50 COI = 153% of age 40 COI, age 60 COI = 180% of age 50 COI, age 70 COI = 233% of age 60 COI, and all these before medical inflation.
https://www.prudential.com.my/export/sites/prudential-pamb/.galleries/pdf/en/listing/PRUMillion-Med-COI.pdf

Current average age of policyholder for big4 should be ~age40.
Under IFRS4, future margin doesn't include in profit calculation, under IFRS17, a portion of future margin is included in profit calculation.

Stock

2024-01-15 16:04 | Report Abuse

break 20 tomorrow?
maybe 22 when YE23 results out.

Medical business might be a loss if there is no reprice for a while, but usually will have 20-30% margin upon repricing (reflecting next 2-3 years inflation). e.g. first year after repricing 30% margin, second year 20% margin, third year 10% margin, then another round of repricing again. Margin on medical insurance is the key source of profit for big4 players.

Stock

2024-01-10 14:20 | Report Abuse

Cost of insurance for medical, will increase over time, as policyholder ages, and due to medical inflation. Assuming nothing will change, the yearly absolute margin from medical business will grow at at least 2x of inflation rate.

Some might say, CSM (PV profit) should already capture all these and current reporting should already reflecting all these, but actually is no. Actuaries will not project medical inflation (~8% p.a.) until end of policy term, as it will give very extremely high number that very hard to explain.

Stock

2024-01-10 14:15 | Report Abuse

No idea with Allianz, but can easily guess from Prudential and GE. Prudential with 73% claims from medical and GE with 55% claims from medical.

Total claims paid by Allianz Life = ~1.7bil in 2022, medical claims estimated to be ~0.9bil-1.2bil.
Margin usually in the range of 20%, i.e. 0.3bil (cost of insurance for medical - claims paid), depending on the repricing cycle, will be more profitable when it is just "freshly" reprice, will be least profitable when the last reprice is long time ago.
vs IFRS17 full year profit of 0.4bil.

If BNM delay repricing approval for one year, assuming 10% inflation, it will wipe out ~120mil profit for Allianz.

Nobody will happy with medical inflation, people will eventually drop coverage when it is not supportable. The key issue is because customers like cashless admission, not knowing the consequences of it. Singapore has already mandatory all medical insurance to have coinsurance/deductible. Suspect Malaysia will soon follow, if BNM/MOH is smart. However, changing to coinsurance/deductible, while will make medical business more sustainable, it will have immediate short term effect where the COI collected will reduce, and impact the short term profit.

Another key change is the rumor that government will end the RM1 treatment for government hospital, and will launch something like Singapore medishield/social insurance/社保.
This will change the landscape dramatically. e.g. can people with private medical insurance opt-out? (if can, then this social insurance will be a failure with substandard life)
If cannot opt out, then majority will have 2 insurances (or 3 if included insurance from employer).
People might drop out from the private medical insurance as well.
Regardless, personally I dont think social insurance (in any form) in Malaysia will success, especially under leadership of Anwar.

Stock

2024-01-10 10:56 | Report Abuse

I foresee there will be another small bump in share price when YE23 result is out. Then throughout entire 2024 will be rather stable.

Future spike will depend on medical business management (how often Allianz will do the repricing), medical inflation, MOH policies, and new business market share.

Stock

2024-01-10 10:50 | Report Abuse

dividend payment before CNY, huat ar

Stock

2023-12-18 11:37 | Report Abuse

Allianz on viagra again

Stock

2023-11-25 07:52 | Report Abuse

It will not fully cancel out another. Actually in fact, 69mil as impact of assumption change is very immaterial.
CSM release % from 6% (HY23) to 9.2% (Q3) also not a material change.

Expected growth in the CSM is coming from the discount rate (risk free).
Imagine you will earn 100 in Dec 2023.
Initially in Dec 2022, you will PV for one full year, say PV(m0)
Then in Jun 2023, you will PV for half year, say PV(m6) , and this number will bigger than PV(m0).
That is the expected growth.
This will present as a cost actually in P/L, and to be offset with actual investment return, for GMM.
For VFA, this will be slightly difference.

Stock

2023-11-24 14:50 | Report Abuse

重磅独家|马中互访免签 赴华15天 来马30天 - 国内 - 即时国内

Stock

2023-11-24 11:25 | Report Abuse

AmIB directly use CSM to value Allianz Life.
A couple of issue:
1. 3.3bil CSM is gross RI, gross tax
2. net CSM is much lower at 2bil
3. future profit is actually CSM + RA. RA is estimated around 15% of CSM for Allianz.
4. VNB should be included

Stock

2023-11-24 11:13 | Report Abuse

increase in CSM due to assumption change. Page7, note1, Increase in CSM is driven by the change in non-financial assumptions mainly due to revision for persistency and mortality assumption